Reach your target audience
An email address is your first line of communication with a customer. Make sure you reach them.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus i...
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.
Read moreBoost your email marketing success with NeverBounce: verify potential email addresses for increased open rates, and maximize engagement!
Analyzing a list provides a good idea of the overall list health and can determine if list cleaning is needed. Try our free list analysis for your leads from Intrado and other companies.
Ensure the accuracy of your email lists with NeverBounce’s automated service. Whether you're evaluating email addresses from Intrado or another company, connect your email provider to NeverBounce for daily cleansing. Our automated system operates continuously, efficiently exporting purified data back to your platform, ensuring the cleanliness of your data.
Daily list cleanings
Automatic import to and from your ESP
Unlimited ESP connections
Whitelist/blacklist options
headquarters:
phone:
website:
www.bms.comrevenue:
stock Symbol:
number Of Employees:
Popular Searches
Industries
Manufacturing|Pharmaceuticals
Validating Bristol-Myers Squibb email addresses can be accomplished using NeverBounce, a tool that simplifies the verification and cleaning of email lists automatically.
Reach your target audience
An email address is your first line of communication with a customer. Make sure you reach them.
The most used email format in Bristol-Myers Squibb is John.Smith@bms.com in 86.5% of the time
Reach your target audience
An email address is your first line of communication with a customer. Make sure you reach them.